Skip to content

24 Jul 2026

Bioavailability is more than the ingredient

Two products with the same label claim can deliver very different amounts to the body. Formulation decides which one you make.

It is tempting to compare ingredients by the milligrams on the label. But what reaches the bloodstream depends on a chain of events, and any weak link limits the whole.

The absorption chain

  1. Release. The dosage form has to break up and release the active.
  2. Dissolve. The active has to go into solution in the fluid it meets.
  3. Permeate. It has to cross the gut wall.
  4. Survive. It must not be destroyed by acid, enzymes or first-pass metabolism along the way.

Matching the fix to the weak link

A poorly soluble active gains most from dissolution-side work — smaller particles, a solid dispersion, or a lipid carrier. A soluble but poorly permeable one needs a different approach. An acid-labile active needs protection, such as an enteric coating.

This is why pre-formulation matters: measuring solubility, permeability and stability first tells you which link to strengthen, instead of guessing.

Working through a formulation problem?

Send us the details — a short conversation often saves a batch.

Contact us